File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3390/ph3103343
- Scopus: eid_2-s2.0-78650096838
- WOS: WOS:000437570600014
Supplementary
- Citations:
- Appears in Collections:
Article: Anti-viral drugs for human adenoviruses
Title | Anti-viral drugs for human adenoviruses |
---|---|
Authors | |
Keywords | Adenovirus microRNA Pharmaceuticals |
Issue Date | 2010 |
Citation | Pharmaceuticals, 2010, v. 3, n. 10, p. 3343-3354 How to Cite? |
Abstract | There are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A-F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed. © 2010 by the authors. |
Persistent Identifier | http://hdl.handle.net/10722/311922 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Waye, MMY | - |
dc.contributor.author | Sing, CW | - |
dc.date.accessioned | 2022-04-06T04:31:46Z | - |
dc.date.available | 2022-04-06T04:31:46Z | - |
dc.date.issued | 2010 | - |
dc.identifier.citation | Pharmaceuticals, 2010, v. 3, n. 10, p. 3343-3354 | - |
dc.identifier.uri | http://hdl.handle.net/10722/311922 | - |
dc.description.abstract | There are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A-F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed. © 2010 by the authors. | - |
dc.language | eng | - |
dc.relation.ispartof | Pharmaceuticals | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Adenovirus | - |
dc.subject | microRNA | - |
dc.subject | Pharmaceuticals | - |
dc.title | Anti-viral drugs for human adenoviruses | - |
dc.type | Article | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3390/ph3103343 | - |
dc.identifier.scopus | eid_2-s2.0-78650096838 | - |
dc.identifier.volume | 3 | - |
dc.identifier.issue | 10 | - |
dc.identifier.spage | 3343 | - |
dc.identifier.epage | 3354 | - |
dc.identifier.eissn | 1424-8247 | - |
dc.identifier.isi | WOS:000437570600014 | - |